3 days Ago By ABMN Staff
Walgreens Boots Alliance, Inc. ( NASDAQ:WBA – Get Free Report ) saw a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 82,910,000 shares, a growth of 15.
2% from the August 15th total of 71,970,000 shares. Approximately 11.7% of the company’s stock are short sold.
Based on an average daily volume of 20,900,000 shares, the short-interest ratio is currently 4.0 days. Walgreens Boots Alliance Trading Up 4.
2 % Shares of NASDAQ:WBA opened at $9.21 on Monday. The company has a market cap of $7.
95 billion, a PE ratio of -1.37, a P/E/G ratio of 0.98 and a beta of 0.
70. The company’s 50 day moving average is $10.51 and its two-hundred day moving average is $15.
10. Walgreens Boots Alliance has a 52 week low of $8.46 and a 52 week high of $27.
05. The company has a current ratio of 0.65, a quick ratio of 0.
31 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance ( NASDAQ:WBA – Get Free Report ) last announced its quarterly earnings results on Thursday, June 27th.
The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.
05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.
63%. The company had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.
94 billion. During the same period last year, the firm earned $1.00 earnings per share.
Walgreens Boots Alliance’s revenue was up 2.8% on a year-over-year basis. Equities analysts predict that Walgreens Boots Alliance will post 2.
87 earnings per share for the current fiscal year. Walgreens Boots Alliance Announces Dividend Institutional Investors Weigh In On Walgreens Boots Alliance A number of institutional investors have recently added to or reduced their stakes in WBA. Quadrant Capital Group LLC lifted its stake in shares of Walgreens Boots Alliance by 33.
8% in the fourth quarter. Quadrant Capital Group LLC now owns 7,494 shares of the pharmacy operator’s stock valued at $196,000 after purchasing an additional 1,893 shares during the period. Syon Capital LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $333,000.
EP Wealth Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $297,000. Corient Private Wealth LLC increased its stake in Walgreens Boots Alliance by 38.9% in the 4th quarter.
Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock valued at $7,325,000 after purchasing an additional 78,523 shares in the last quarter. Finally, Sanders Morris Harris LLC raised its holdings in Walgreens Boots Alliance by 373.3% during the first quarter.
Sanders Morris Harris LLC now owns 112,398 shares of the pharmacy operator’s stock worth $2,438,000 after purchasing an additional 88,650 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.
Analyst Upgrades and Downgrades Several equities analysts have recently issued reports on WBA shares. Barclays reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.
00 and set an “underweight” rating for the company in a report on Tuesday, July 23rd. Bank of America reduced their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.
50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. TD Cowen dropped their price target on Walgreens Boots Alliance from $22.00 to $16.
00 and set a “buy” rating for the company in a report on Thursday. Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $13.00 to $9.
00 and set an “underweight” rating for the company in a report on Friday, June 28th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Walgreens Boots Alliance from $20.
00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the stock.
According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $14.73. View Our Latest Analysis on WBA About Walgreens Boots Alliance ( Get Free Report ) Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
It operates through three segments: U.S. Retail Pharmacy, International, and U.
S. Healthcare. The U.
S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. See Also Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.
com's FREE daily email newsletter ..
